221 related articles for article (PubMed ID: 408218)
21. Utility of a 13C-methacetin breath test in evaluating hepatic injury in rats.
Shirin H; Aeed H; Shalev T; Sorin V; Stavinski S; Shahmurov M; Ilan Y; Avni Y
J Gastroenterol Hepatol; 2008 Nov; 23(11):1762-8. PubMed ID: 19120861
[TBL] [Abstract][Full Text] [Related]
22. [Necrosis in alcoholic hepatopathies].
Enríquez L; Díaz-Rubio García M; Zamarrón A; Díaz-Rubio M
Rev Esp Enferm Apar Dig; 1972 Jun; 37(6):679-702. PubMed ID: 5048000
[No Abstract] [Full Text] [Related]
23. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients.
Ong JP; Elariny H; Collantes R; Younoszai A; Chandhoke V; Reines HD; Goodman Z; Younossi ZM
Obes Surg; 2005 Mar; 15(3):310-5. PubMed ID: 15826462
[TBL] [Abstract][Full Text] [Related]
24. Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis.
Contos MJ; Cales W; Sterling RK; Luketic VA; Shiffman ML; Mills AS; Fisher RA; Ham J; Sanyal AJ
Liver Transpl; 2001 Apr; 7(4):363-73. PubMed ID: 11303298
[TBL] [Abstract][Full Text] [Related]
25. Predictive factors for the severity of liver fibrosis in patients with chronic hepatitis C and moderate alcohol consumption.
Vădan R; Gheorghe L; Becheanu G; Iacob R; Iacob S; Gheorghe C
Rom J Gastroenterol; 2003 Sep; 12(3):183-7. PubMed ID: 14502317
[TBL] [Abstract][Full Text] [Related]
26. [Macrocytosis and anemia in chronic alcoholism. Correlation with the results of hepatic needle biopsy].
Gheno G; Magnabosco V; Mazzei G
Minerva Med; 1981 May; 72(20):1301-6. PubMed ID: 7243021
[TBL] [Abstract][Full Text] [Related]
27. Factors determining liver damage in chronic alcoholics.
Eghöje KN; Juhl E
Scand J Gastroenterol; 1973; 8(6):505-12. PubMed ID: 4772204
[No Abstract] [Full Text] [Related]
28. II. Veterans Affairs Cooperative Study of polyenylphosphatidylcholine in alcoholic liver disease.
Lieber CS; Weiss DG; Groszmann R; Paronetto F; Schenker S;
Alcohol Clin Exp Res; 2003 Nov; 27(11):1765-72. PubMed ID: 14634492
[TBL] [Abstract][Full Text] [Related]
29. Editorial: Biopsy in alcoholic liver disease.
Lough J
Can Med Assoc J; 1974 May; 110(10):1121 passim. PubMed ID: 4829830
[No Abstract] [Full Text] [Related]
30. Predictors of steatohepatitis and advanced fibrosis in non-alcoholic fatty liver disease.
Pagadala M; Zein CO; McCullough AJ
Clin Liver Dis; 2009 Nov; 13(4):591-606. PubMed ID: 19818307
[TBL] [Abstract][Full Text] [Related]
31. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC
Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
[TBL] [Abstract][Full Text] [Related]
32. Tissue inhibitor of metalloproteinase is increased in the serum of precirrhotic and cirrhotic alcoholic patients and can serve as a marker of fibrosis.
Li J; Rosman AS; Leo MA; Nagai Y; Lieber CS
Hepatology; 1994 Jun; 19(6):1418-23. PubMed ID: 8188171
[TBL] [Abstract][Full Text] [Related]
33. Pancreatic fibrosis in patients with alcoholic dependence syndrome.
Suda K; Akai J; Nakamura T
Arch Pathol Lab Med; 1993 Oct; 117(10):1013-6. PubMed ID: 8215822
[TBL] [Abstract][Full Text] [Related]
34. Letter: Alcoholic cirrhosis in baboons.
N Engl J Med; 1974 Apr; 290(16):910-2. PubMed ID: 4131614
[No Abstract] [Full Text] [Related]
35. Steatosis and liver cell apoptosis in chronic hepatitis C: a mechanism for increased liver injury.
Walsh MJ; Vanags DM; Clouston AD; Richardson MM; Purdie DM; Jonsson JR; Powell EE
Hepatology; 2004 May; 39(5):1230-8. PubMed ID: 15122751
[TBL] [Abstract][Full Text] [Related]
36. Effect of steatosis and inflammation on liver fibrosis in chronic hepatitis C.
Nieminen U; Arkkila PE; Kärkkäinen P; Färkkilä MA
Liver Int; 2009 Feb; 29(2):153-8. PubMed ID: 18482270
[TBL] [Abstract][Full Text] [Related]
37. Abnormal glucose tolerance is a predictor of steatohepatitis and fibrosis in patients with non-alcoholic fatty liver disease.
Haukeland JW; Konopski Z; Linnestad P; Azimy S; Marit Løberg E; Haaland T; Birkeland K; Bjøro K
Scand J Gastroenterol; 2005 Dec; 40(12):1469-77. PubMed ID: 16293559
[TBL] [Abstract][Full Text] [Related]
38. The impact of hepatic steatosis on the natural history of chronic hepatitis C infection.
Cross TJ; Quaglia A; Hughes S; Joshi D; Harrison PM
J Viral Hepat; 2009 Jul; 16(7):492-9. PubMed ID: 19200134
[TBL] [Abstract][Full Text] [Related]
39. Predicting progressive hepatic fibrosis stage on subsequent liver biopsy in chronic hepatitis C virus infection.
Collier JD; Woodall T; Wight DG; Shore S; Gimson AE; Alexander GJ
J Viral Hepat; 2005 Jan; 12(1):74-80. PubMed ID: 15655051
[TBL] [Abstract][Full Text] [Related]
40. Alcohol is an important co-factor for both steatosis and fibrosis in Northern Italian patients with chronic hepatitis C.
Fabris P; Floreani A; Carlotto A; Giordani MT; Baldo V; Stecca C; Marchioro L; Tramarin A; Bertin T; Negro F; de Lalla F
J Hepatol; 2004 Oct; 41(4):644-51. PubMed ID: 15464246
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
